Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients
Amir Moheet, Daniel Beisang, Lin Zhang, Scott D. Sagel, Jill M. VanDalfsen, Sonya L. Heltshe, Carla Frederick, Michelle Mann, Nicholas Antos, Joanne Billings, Steven M. Rowe, Antoinette Moran
Topics & Concepts
IvacaftorMedicineCystic fibrosisInternal medicineInsulinIntensive care medicineEndocrinologyCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesImmunodeficiency and Autoimmune DisordersBiological Research and Disease Studies